MAPT and Brain atrophy: PSP‐P shows a milder severity and slower disease progression than PSP‐RS, associated with a lower degree of brain atrophy detected by MRI and less severe and diffuse tau deposition.2, 3, 4, 5, 10, 13, 36, 37, 38